Detailed view for Tb927.9.270

Basic information

TDR Targets ID: 12708
Trypanosoma brucei, variant surface glycoprotein (VSG, atypical), putative
Source Database / ID:  TriTrypDB  GeneDB

pI: 7.2509 | Length (AA): 508 | MW (Da): 54924 | Paralog Number: 3

Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 0

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF10659   Trypanosome variant surface glycoprotein C-terminal domain
PF13206   Trypanosomal VSG domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0020033   antigenic variation  
GO:0016021   integral to membrane  

Metabolic Pathways

African trypanosomiasis (KEGG)

Structural information

Modbase 3D models:

No model available for this protein in Modbase.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
NA% percentile Procyclic. Siegel TN
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile Bloodstream Form. Siegel TN
Show/Hide expression data references
  • Siegel TN Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites.

Orthologs

Ortholog group members (OG5_139887)

Species Accession Gene Product
Trypanosoma brucei Tb08.27P2.710   variant surface glycoprotein, degenerate
Trypanosoma brucei Tb11.v5.0595   variant surface glycoprotein (VSG), putative
Trypanosoma brucei Tb927.9.270   variant surface glycoprotein (VSG, atypical), putative
Trypanosoma brucei Tb927.11.17170   variant surface glycoprotein (VSG), degenerate
Trypanosoma congolense TcIL3000_0_48020   variant surface glycoprotein (VSG), putative
Trypanosoma congolense TcIL3000_0_20400   variant surface glycoprotein (VSG), putative

Essentiality

No essentiality data collected for this gene and/or its orthologs.

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Staphylococcus aureus (strain N315) Probable nicotinate-nucleotide adenylyltransferase 189 aa 20.5% 171 aa Compounds References
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Tb927.9.270 (Trypanosoma brucei), variant surface glycoprotein (VSG, atypical), putative
Title for this comment
Comment